Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Celcuity Inc (CELC)

Celcuity Inc (CELC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 405,831
  • Shares Outstanding, K 37,130
  • Annual Sales, $ 0 K
  • Annual Income, $ -63,780 K
  • EBIT $ -97 M
  • EBITDA $ -96 M
  • 60-Month Beta 0.74
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.70

Options Overview Details

View History
  • Implied Volatility 165.17% ( +18.71%)
  • Historical Volatility 55.86%
  • IV Percentile 99%
  • IV Rank 89.31%
  • IV High 183.59% on 01/14/25
  • IV Low 11.37% on 06/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 301
  • Open Int (30-Day) 361

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.72
  • Number of Estimates 4
  • High Estimate -0.65
  • Low Estimate -0.80
  • Prior Year -0.65
  • Growth Rate Est. (year over year) -10.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.35 +8.27%
on 01/13/25
13.91 -19.41%
on 12/27/24
-1.25 (-10.03%)
since 12/20/24
3-Month
10.35 +8.27%
on 01/13/25
16.54 -32.24%
on 11/07/24
-4.92 (-30.50%)
since 10/21/24
52-Week
10.35 +8.27%
on 01/13/25
22.19 -49.48%
on 03/28/24
-3.55 (-24.05%)
since 01/19/24

Most Recent Stories

More News
Celcuity Inc. Reports Encouraging Overall Survival Data for Gedatolisib in Advanced HR+/HER2- Breast Cancer患者

Celcuity announces promising overall survival data for gedatolisib in HR+, HER2- advanced breast cancer at SABCS.Quiver AI SummaryCelcuity Inc. announced new overall survival (OS) data from a Phase 1b...

CELC : 11.21 (+2.56%)
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

CELC : 11.21 (+2.56%)
Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

CELC : 11.21 (+2.56%)
Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences

CELC : 11.21 (+2.56%)
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

CELC : 11.21 (+2.56%)
Top Five Cancer Types Dominate New US Cases as Biotech Sector Eyes $314B Market by 2032

/CNW/ -- According to a "highly troubling" new study, the rising number of cancer cases in young people is being attributed to "accelerated aging." Further...

ONCY : 0.8360 (+5.69%)
CELC : 11.21 (+2.56%)
OLMA : 5.50 (-2.83%)
BIO : 353.86 (+3.34%)
AZN : 67.96 (+2.04%)
ONC.TO : 1.18 (unch)
Biotech's Developments in Race Against Rising Cancer Rates Revealed

USA News Group – According to a “highly troubling” new study, the rising number of cancer cases in young people is being attributed to “accelerated aging.” Further alarm is being spread by the...

ONCY : 0.8360 (+5.69%)
ONC.TO : 1.18 (unch)
CELC : 11.21 (+2.56%)
OLMA : 5.50 (-2.83%)
BIO : 353.86 (+3.34%)
AZN : 67.96 (+2.04%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Celcuity Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

CELC : 11.21 (+2.56%)
Celcuity Announces FDA Breakthrough Therapy Designation for Gedatolisib for Treatment of HR+/HER2- Metastatic Breast Cancer

MINNEAPOLIS, MN / ACCESSWIRE / July 18, 2022 / Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for hormonally driven cancers, today announced...

CELC : 11.21 (+2.56%)
Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences

MINNEAPOLIS, MN / ACCESSWIRE / May 26, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients...

CELC : 11.21 (+2.56%)

Business Summary

Celcuity Inc. is a cellular analysis company. It engaged in discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses a patient's...

See More

Key Turning Points

3rd Resistance Point 11.96
2nd Resistance Point 11.66
1st Resistance Point 11.43
Last Price 11.21
1st Support Level 10.91
2nd Support Level 10.61
3rd Support Level 10.39

See More

52-Week High 22.19
Fibonacci 61.8% 17.67
Fibonacci 50% 16.27
Fibonacci 38.2% 14.87
Last Price 11.21
52-Week Low 10.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar